These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35934321)

  • 21. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
    Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
    Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).
    van Agthoven T; Looijenga LHJ
    Oncotarget; 2017 Aug; 8(35):58037-58049. PubMed ID: 28938535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration.
    Radtke A; Dieckmann KP; Grobelny F; Salzbrunn A; Oing C; Schulze W; Belge G
    Andrology; 2019 Jul; 7(4):469-474. PubMed ID: 31310058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
    Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
    Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures.
    Santarosa Vieira AG; da Silva LS; Albino da Silva EC; Laus AC; Faria TMV; van Helvoort Lengert A; Martins GE; de Oliveira MA; Reis RM; Lopes LF; Pinto MT
    Mol Oncol; 2024 Jun; 18(6):1593-1607. PubMed ID: 38725152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
    Murray MJ; Ajithkumar T; Harris F; Williams RM; Jalloh I; Cross J; Ronghe M; Ward D; Scarpini CG; Nicholson JC; Coleman N
    Neurooncol Adv; 2020; 2(1):vdaa048. PubMed ID: 32642701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
    Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range.
    Lafin J; Scarpini C; Amini A; Konneh B; Howard J; Gerald T; Nuno M; Piao J; Savelyeva A; Wang Z; Gagan J; Jia L; Lewis C; Murray S; Sawa Y; Margulis V; Woldu S; Strand D; Coleman N; Amatruda J; Frazier L; Murray M; Bagrodia A
    Res Sq; 2023 Mar; ():. PubMed ID: 36993198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
    Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
    Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma.
    Belge G; Grobelny F; Matthies C; Radtke A; Dieckmann KP
    In Vivo; 2020; 34(1):163-168. PubMed ID: 31882475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor.
    Belge G; Hennig F; Dumlupinar C; Grobelny F; Junker K; Radtke A; Dieckmann KP
    Oncotarget; 2020 Apr; 11(16):1462-1473. PubMed ID: 32363003
    [No Abstract]   [Full Text] [Related]  

  • 34. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
    Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens.
    Kremer L; von Brandenstein M; Wittersheim M; Koeditz B; Paffenholz P; Hellmich M; Pfister D; Heidenreich A; Nestler T
    Transl Androl Urol; 2021 Apr; 10(4):1647-1655. PubMed ID: 33968653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
    Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
    Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.
    Schönberger S; Mohseni MM; Ellinger J; Tran GVQ; Becker M; Claviez A; Classen CF; Hermes B; Driever PH; Jorch N; Lauten M; Mehlitz M; Schäfer N; Scheer-Preiss J; Schneider DT; Troeger A; Calaminus G; Dilloo D
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):791-802. PubMed ID: 35171328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring.
    Murray MJ; Scarpini CG; Coleman N
    Methods Mol Biol; 2021; 2195():225-243. PubMed ID: 32852767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.